SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

Clinical trial NCT05801627 · COMPLETED

Trial details

NCT number: NCT05801627
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2020-05-06
Primary completion: 2022-05-24
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.